Mediators of Inflammation / 2014 / Article / Tab 1

Research Article

The Influence of Autologous Bone Marrow Stem Cell Transplantation on Matrix Metalloproteinases in Patients Treated for Acute ST-Elevation Myocardial Infarction

Table 1

Characteristics of the study population according to the randomized groups. Values are presented as proportion, means ± SD, or medians1 with 25th and 75th percentiles.

mBMC group ()Control group ()

Age (years)58.1 (8.6)56.7 (9.6)
Gender (% female)1616
Hypertension (%)3534
Diabetes (%)108
Smokers (%)3948
BMI (kg/m2)26.3 (3.3)27.1 (4.1)
SBP/DBP (mmHg)131/82 ± 21/14132/83 ± 23/17
Tot. chol (mmol/L)4.4 ± 0.94.5 ± 0.9
LDL chol (mmol/L)2.9 ± 0.82.9 ± 0.7
HDL chol (mmol/L)1.0 ± 0.31.1 ± 0.3
Triglycerides (mmol/L)11.3 (1.0, 1.7)1.3 ± (1.1, 1.5)
Symptom start to PCI (min)1210 (180, 330)230 (180, 330)
LVEF (%)41.3 (10.6)42.6 (11.7)
Infarct size (%) 43.7 ± 17.640.7 ± 19.3
Peak CK (U/L)3338 ± 23983532 ± 2650
Thrombolysis before PCI (%)3028
Medication at discharge
 Aspirin (%)100100
 Clopidogrel (%)100100
 ACE-I/ATII antagonist (%)100100
-blocker (%)100100
 Diuretics (%)4332
 Statin (%)100100

ATII antagonist: angiotensin II receptor antagonist; ACE-I: angiotensin-converting enzyme inhibitor; BMI: body mass index; DBP: diastolic blood pressure; LVEF: left ventricular ejection fraction; PCI: percutaneous coronary intervention; and SBP: systolic blood pressure.